THE COVID-19 SUPPLY CHAIN: Fact not Fiction
Digging deeper in COVID Supply Chains
Given my specialist subject, Supply Chain Management in the Drug Industry, I’m thinking that subscribers may want me to focus on what I know after 40 years in the pharmaceutical industry. Then, I was a thought leader and modernizer who was highly regarded. Take a look at the reviews for my book written in 2011:
Example:
"37 years in the industry but I never saw the production side in this light; I have learned a lot. I will write 2 reviews, one for general audiences and one for the trial lawyers who need to read it in their efforts to remediate injuries from generic drugs that had unexpectedly adverse effects. Using charts, graphic imagery and guest writers' insightful comments, this text delivers an excellent message for the corporate executive, the investor in pharma stocks, the regulatory professional and (last and least) the lawyer…